Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Bladder Cancer · Urothelial Carcinoma · Metastatic Urothelial Carcinoma · Locally Advanced Urothelial Carcinoma · Upper Tract Urothelial Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Contact: Study coordinator (Zhen J Peng, Phd) · Zhen-Peng@beijing-biotech.com · +86 13076790039

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Solid Tumor, Adult · Bladder Cancer · Urothelial Carcinoma

Abroad (travel likely)RecruitingPHASE1

North Melbourne, Australia

Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)

Urothelial Carcinoma · Lynch Syndrome

Abroad (travel likely)Recruiting

Vancouver, Canada · Tampere, Finland

9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Carcinoma · Urothelial Carcinoma Bladder · Urothelial Carcinoma Recurrent

Abroad (travel likely)RecruitingPHASE2

Changsha, China · Nanjing, China

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Urothelial Carcinoma

IsraelRecruitingPHASE2

Gilbert, United States · Gilbert, United States